Vireo Growth (VREOF) Net Income towards Common Stockholders Growth (5y) (2025 - 2026)

Vireo Growth (VREOF) Net Income towards Common Stockholders Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.33 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.15 Bn	19.48 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.56 Bn	15.17 Bn	935.80 Mn
8	Elanco Animal Health	11.74 Bn	11.21 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-
10	Vireo Growth	491.44 Mn	349.14 Mn	95.30 Mn

Download Data